Affinity Asset Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
Other funds holding ENTA
Affinity Asset Advisors's ENTA Position: Q3 2026 in Review
Affinity Asset Advisors opened a new position in Enanta Pharmaceuticals (ENTA) in Q3 2026: 29,300 shares worth $386K. The stake represents 0.02% of the portfolio and ranks #119 among its holdings.
125 funds tracked by Wall St. Rank hold ENTA as of Q3 2026.
- Affinity Asset Advisors held 29,300 shares of Enanta Pharmaceuticals worth $386K as of Q3 2026.
- Enanta Pharmaceuticals was a new Affinity Asset Advisors position in Q3 2026.
- Enanta Pharmaceuticals made up 0.02% of Affinity Asset Advisors's portfolio in Q3 2026, its #119 holding.
- 125 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2026.
Based on Affinity Asset Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.